相似文献
1
Comment on: oxidative stress and antioxidant status in beta-thalassemia heterozygotes.
Rev Bras Hematol Hemoter. 2013;35(6):385-6. doi: 10.5581/1516-8484.20130125.
2
Oxidative stress and antioxidant status in beta-thalassemia heterozygotes.
Rev Bras Hematol Hemoter. 2013;35(6):409-13. doi: 10.5581/1516-8484.20130122.
3
Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in Beta thalassemia major patients: a review of the literature.
Anemia. 2012;2012:270923. doi: 10.1155/2012/270923. Epub 2012 May 9.
4
Oxidative status in the β-thalassemia syndromes in Sri Lanka; a cross-sectional survey.
Free Radic Biol Med. 2021 Apr;166:337-347. doi: 10.1016/j.freeradbiomed.2021.02.028. Epub 2021 Mar 4.
5
Oxidative stress in patients with beta-thalassemia major.
Prilozi. 2007 Jul;28(1):145-54.
6
Bilirubin concentrations in thalassemia heterozygotes in university students.
Eur J Haematol. 2011 Apr;86(4):317-23. doi: 10.1111/j.1600-0609.2011.01578.x.
7
The benefits of vitamin C and vitamin E in children with beta-thalassemia with high oxidative stress.
J Med Assoc Thai. 2005 Sep;88 Suppl 4:S317-21.
8
Treatment of β-Thalassemia/Hemoglobin E with Antioxidant Cocktails Results in Decreased Oxidative Stress, Increased Hemoglobin Concentration, and Improvement of the Hypercoagulable State.
Oxid Med Cell Longev. 2015;2015:537954. doi: 10.1155/2015/537954. Epub 2015 May 19.
9
The impact of silymarin on antioxidant and oxidative status in patients with β-thalassemia major: A crossover, randomized controlled trial.
Complement Ther Med. 2017 Dec;35:25-32. doi: 10.1016/j.ctim.2017.08.007. Epub 2017 Aug 24.
10
Lipid peroxidation and antioxidant status in beta-thalassemia.
Pediatr Hematol Oncol. 2000 Dec;17(8):687-93. doi: 10.1080/08880010050211402.
引用本文的文献
1
Respiratory Burst Enzymes, Pro-Oxidants and Antioxidants Status in Bangladeshi Population with β-Thalassemia Major.
N Am J Med Sci. 2015 Jun;7(6):253-8. doi: 10.4103/1947-2714.159329.
本文引用的文献
1
Pattern of β-Thalassemia and Other Haemoglobinopathies: A Cross-Sectional Study in Bangladesh.
ISRN Hematol. 2012;2012:659191. doi: 10.5402/2012/659191. Epub 2012 Jun 14.
2
Immunological evaluation of patients with beta-thalassemia major.
Acta Haematol. 2001;105(1):7-12. doi: 10.1159/000046526.
3
Lipid peroxidation and antioxidant status in beta-thalassemia.
Pediatr Hematol Oncol. 2000 Dec;17(8):687-93. doi: 10.1080/08880010050211402.
4
Oxidative stress and antioxidant status in beta-thalassemia major: iron overload and depletion of lipid-soluble antioxidants.
Blood. 1996 Nov 1;88(9):3608-14.
5
Increased erythrocyte superoxide dismutase activities in beta 0-thalassaemia/haemoglobin E and in haemoglobin H diseases.
J Clin Pathol. 1983 Mar;36(3):329-33. doi: 10.1136/jcp.36.3.329.
6
Catalase: a tetrameric enzyme with four tightly bound molecules of NADPH.
Proc Natl Acad Sci U S A. 1984 Jul;81(14):4343-7. doi: 10.1073/pnas.81.14.4343.
7
Catalase activity and red cell metabolism.
Adv Exp Med Biol. 1972;28:121-31. doi: 10.1007/978-1-4684-3222-0_8.
8
Antioxidant system and serum trace elements in alpha-thalassaemia and Hb Lepore trait.
Eur J Haematol. 1987 Jul;39(1):23-7. doi: 10.1111/j.1600-0609.1987.tb00158.x.
9
Heterozygous beta-thalassemia: relationship between the hematological phenotype and the type of beta-thalassemia mutation.
Am J Hematol. 1992 Jan;39(1):1-4. doi: 10.1002/ajh.2830390102.
Zotero 插件